Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Uriry Incontinence - Overview
Uriry Incontinence - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Uriry Incontinence - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Uriry Incontinence - Companies Involved in Therapeutics Development
Allergan Ltd
Cook MyoSite Inc
Crystec Ltd
FemmePharma Global Healthcare Inc
Innovacell Biotechnologie AG
Ixaltis
Johnson & Johnson
Ningbo Xijian Pharmaceutical Technology Co Ltd
Outpost Medicine Ltd
Pfizer Inc
Profem GmbH
Revance Therapeutics Inc
Sanio AB
Taiho Pharmaceutical Co Ltd
Uriry Incontinence - Drug Profiles
Cell Therapy for Gastrointestil Disorders, Ischemic Heart Failure and Urological Diseases - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Cell Therapy for Uriry Incontinence - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Uriry Incontinence - Dormant Projects
Uriry Incontinence - Discontinued Products
Uriry Incontinence - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Urinary Incontinence, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Urinary Incontinence, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Urinary Incontinence - Pipeline by Allergan Ltd, H2 2020
Urinary Incontinence - Pipeline by Cook MyoSite Inc, H2 2020
Urinary Incontinence - Pipeline by Crystec Ltd, H2 2020
Urinary Incontinence - Pipeline by FemmePharma Global Healthcare Inc, H2 2020
Urinary Incontinence - Pipeline by Innovacell Biotechnologie AG, H2 2020
Urinary Incontinence - Pipeline by Ixaltis, H2 2020
Urinary Incontinence - Pipeline by Johnson & Johnson, H2 2020
Urinary Incontinence - Pipeline by Ningbo Xijian Pharmaceutical Technology Co Ltd, H2 2020
Urinary Incontinence - Pipeline by Outpost Medicine Ltd, H2 2020
Urinary Incontinence - Pipeline by Pfizer Inc, H2 2020
Urinary Incontinence - Pipeline by Profem GmbH, H2 2020
Urinary Incontinence - Pipeline by Revance Therapeutics Inc, H2 2020
Urinary Incontinence - Pipeline by Saniona AB, H2 2020
Urinary Incontinence - Pipeline by Taiho Pharmaceutical Co Ltd, H2 2020
Urinary Incontinence - Dormant Projects, H2 2020
Urinary Incontinence - Dormant Projects, H2 2020 (Contd..1), H2 2020
Urinary Incontinence - Dormant Projects, H2 2020 (Contd..2), H2 2020
Urinary Incontinence - Discontinued Products, H2 2020